Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis. Issue 3 (10th October 2019)
- Record Type:
- Journal Article
- Title:
- Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis. Issue 3 (10th October 2019)
- Main Title:
- Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis
- Authors:
- Chang, Yoosoo
Ryu, Seungho
Kim, Yejin
Cho, Yong Kyun
Sung, Eunju
Kim, Han‐Na
Ahn, Jiin
Jung, Hyun‐Suk
Yun, Kyung Eun
Kim, Seolhye
Sung, Ki‐Chul
Sohn, Chong Il
Shin, Hocheol
Wild, Sarah H.
Byrne, Christopher D. - Abstract:
- Abstract : Background and Aims: The effects of low‐level alcohol consumption on fatty liver disease and the potential for effect modification by obesity is uncertain. We investigated associations among low‐level alcohol consumption, obesity status, and the development of incident hepatic steatosis (HS), either with or without an increase in noninvasive liver fibrosis score category (from low to intermediate or high category). Approach and Results: A total of 190, 048 adults without HS and a low probability of fibrosis with alcohol consumption less than 30 g/day (men) and less than 20 g/day (women) were followed for up to 15.7 years. Alcohol categories of no, light, and moderate consumption were defined as 0, 1‐9.9, and 10‐29.9 g/day (10‐19.9 g/day for women), respectively. HS was diagnosed by ultrasonography, and the probability of fibrosis was estimated using the fibrosis‐4 index (FIB‐4). Parametric proportional hazards models were used to estimate multivariable‐adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). A total of 43, 466 participants developed HS, 2, 983 of whom developed HS with an increase in FIB‐4 index (to intermediate or high scores). Comparing light drinkers and moderate drinkers with nondrinkers, multivariable‐adjusted HRs (95% CI) for incident HS were 0.93 (0.90‐0.95) and 0.90 (0.87‐0.92), respectively. In contrast, comparing light drinkers and moderate drinkers with nondrinkers, multivariable‐adjusted HRs (95% CI) for developing HS plusAbstract : Background and Aims: The effects of low‐level alcohol consumption on fatty liver disease and the potential for effect modification by obesity is uncertain. We investigated associations among low‐level alcohol consumption, obesity status, and the development of incident hepatic steatosis (HS), either with or without an increase in noninvasive liver fibrosis score category (from low to intermediate or high category). Approach and Results: A total of 190, 048 adults without HS and a low probability of fibrosis with alcohol consumption less than 30 g/day (men) and less than 20 g/day (women) were followed for up to 15.7 years. Alcohol categories of no, light, and moderate consumption were defined as 0, 1‐9.9, and 10‐29.9 g/day (10‐19.9 g/day for women), respectively. HS was diagnosed by ultrasonography, and the probability of fibrosis was estimated using the fibrosis‐4 index (FIB‐4). Parametric proportional hazards models were used to estimate multivariable‐adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). A total of 43, 466 participants developed HS, 2, 983 of whom developed HS with an increase in FIB‐4 index (to intermediate or high scores). Comparing light drinkers and moderate drinkers with nondrinkers, multivariable‐adjusted HRs (95% CI) for incident HS were 0.93 (0.90‐0.95) and 0.90 (0.87‐0.92), respectively. In contrast, comparing light drinkers and moderate drinkers with nondrinkers, multivariable‐adjusted HRs (95% CI) for developing HS plus intermediate/high FIB‐4 were 1.15 (1.04‐1.27) and 1.49 (1.33‐1.66), respectively. The association between alcohol consumption categories and incident HS plus intermediate/high FIB‐4 was observed in both nonobese and obese individuals, although the association was stronger in nonobese individuals ( P for interaction by obesity = 0.017). Conclusions: Light/moderate alcohol consumption has differential effects on the development of different stages of fatty liver disease, which is modified by the presence of obesity. … (more)
- Is Part Of:
- Hepatology. Volume 71:Issue 3(2020)
- Journal:
- Hepatology
- Issue:
- Volume 71:Issue 3(2020)
- Issue Display:
- Volume 71, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 71
- Issue:
- 3
- Issue Sort Value:
- 2020-0071-0003-0000
- Page Start:
- 861
- Page End:
- 873
- Publication Date:
- 2019-10-10
- Subjects:
- Heart -- Diseases -- Nursing -- Periodicals
Lungs -- Diseases -- Nursing -- Periodicals
Intensive care nursing -- Periodicals
Foie -- Maladies -- Périodiques
616.362 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1527-3350 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/hep.30867 ↗
- Languages:
- English
- ISSNs:
- 0270-9139
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4295.836000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20476.xml